Genetic Sequencing Current Affairs, GK & News

Pfizer starts study of mRNA Flu vaccine

On September 28, 2021, Pfizer Inc. announced that the first batch of participants have been dosed with the single dose quadrivalent mRNA vaccine in a Phase 1 clinical trial. Highlights Under the phase 1 trial, safety, tolerability, and immunogenicity of the single dose quadrivalent mRNA vaccine will be studied against influenza in healthy adults. mRNA ..

Month: 

Category: 

Topics: